Ibaraki, Japan

Hironobu Hiyoshi


Average Co-Inventor Count = 11.5

ph-index = 4

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 1995-2006

Loading Chart...
5 patents (USPTO):

Title: Hironobu Hiyoshi: Innovator in Pharmaceutical Chemistry

Introduction

Hironobu Hiyoshi, a prominent inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of five patents, his work focuses on innovative compounds that pave the way for new therapeutic possibilities.

Latest Patents

Among Hiyoshi's latest inventions is a patent for an N-aryl-substituted cyclic amine derivative, which acts as an excellent squalene synthase inhibitor. This patent describes a compound represented by a specific formula, indicating a salt or hydrate form. The compound includes various substituents such as an optionally substituted vinyl group or an aromatic ring, with the possibility for integers, carbon, nitrogen, sulfur, or oxygen atoms to be part of its structure. Notably, the invention highlights a 5-membered ring and a non-aromatic cyclic amino or amido group that can be substituted, further demonstrating its innovative potential in medicine.

Career Highlights

Hironobu Hiyoshi works at Eisai Company, Limited, a global pharmaceutical company dedicated to improving medicine and healthcare. His contributions to medical chemistry have not only enhanced the company's research capabilities but have also established him as a key player in innovation within the industry.

Collaborations

Throughout his career, Hiyoshi has collaborated with notable colleagues, including Hironori Ikuta and Kenji Hayashi. These partnerships have facilitated the exchange of ideas and the development of groundbreaking inventions, reinforcing the importance of teamwork in advancing scientific research.

Conclusion

In summary, Hironobu Hiyoshi stands out as a dedicated inventor whose work is crucial to the advancement of pharmaceuticals. His recent patents embody the innovative spirit of his work at Eisai Company, Limited, and his collaborations with fellow researchers reflect a commitment to excellence in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…